0001371285-24-000043.txt : 20240227
0001371285-24-000043.hdr.sgml : 20240227
20240227212756
ACCESSION NUMBER: 0001371285-24-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240225
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEINRAUCH STEVE
CENTRAL INDEX KEY: 0001968590
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36537
FILM NUMBER: 24689817
MAIL ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRUPANION, INC.
CENTRAL INDEX KEY: 0001371285
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98108
BUSINESS PHONE: 888-733-2685
MAIL ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98108
FORMER COMPANY:
FORMER CONFORMED NAME: TRUPANION INC.
DATE OF NAME CHANGE: 20131114
FORMER COMPANY:
FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC
DATE OF NAME CHANGE: 20060802
4
1
wk-form4_1709087262.xml
FORM 4
X0508
4
2024-02-25
0
0001371285
TRUPANION, INC.
TRUP
0001968590
WEINRAUCH STEVE
6100 4TH AVENUE S
SUITE 200
SEATTLE
WA
98108
0
1
0
0
EVP, North Am & Vet Strategy
0
Common Stock
2024-02-25
4
M
0
1491
A
52464
D
Common Stock
2024-02-25
4
F
0
442
23
D
52022
D
Common Stock
2024-02-25
4
M
0
1106
A
53128
D
Common Stock
2024-02-25
4
F
0
327
23
D
52801
D
Common Stock
2024-02-25
4
M
0
65
A
52866
D
Common Stock
2024-02-25
4
F
0
19
23
D
52847
D
Common Stock
2024-02-25
4
M
0
531
A
53378
D
Common Stock
2024-02-25
4
F
0
157
23
D
53221
D
Common Stock
2024-02-25
4
M
0
163
A
53384
D
Common Stock
2024-02-25
4
F
0
48
23
D
53336
D
Restricted Stock Unit (RSU)
2024-02-25
4
M
0
1491
0
D
2024-02-25
Common Stock
1491
0
D
Restricted Stock Unit (RSU)
2024-02-25
4
M
0
1106
0
D
2025-02-25
Common Stock
1106
4421
D
Restricted Stock Unit (RSU)
2024-02-25
4
M
0
65
0
D
2025-02-25
Common Stock
65
257
D
Restricted Stock Unit (RSU)
2024-02-25
4
M
0
531
0
D
2026-02-25
Common Stock
531
4245
D
Restricted Stock Unit (RSU)
2024-02-25
4
M
0
163
0
D
2027-02-25
Common Stock
163
486
D
Restricted stock units convert into common stock on a one-for-one basis.
This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person.
On April 3, 2020, the reporting person was granted 23,844 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2021, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
On February 22, 2021, the reporting person was granted 17,685 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2022, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
On February 22, 2021, the reporting person was granted 1,028 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2022, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
On February 28, 2022, the reporting person was granted 8,490 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2023, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
On February 27, 2023, the reporting person was granted 649 restricted stock units (RSUs). The RSUs vested and converted into common stock of the Issuer as to 1/4th of the total shares on February 25, 2024, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
/s/ Lauren Welsh as attorney-in-fact for Steve Weinrauch
2024-02-27